CN Patent

CN109020958A — 一种氘代色氨酸羟化酶抑制剂

Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2018-12-18 · 7y expired

What this patent protects

本发明公开了一种结构如式(I)所示氘代色氨酸羟化酶抑制剂化合物及其药学上可接受的盐。本发明还提供了一种式(I)化合物的制备方法及包含本发明化合物的药物组合物及其用途。动物试验表明，本发明化合物具有良好的药代动力学参数和治疗效果。

USPTO Abstract

本发明公开了一种结构如式(I)所示氘代色氨酸羟化酶抑制剂化合物及其药学上可接受的盐。本发明还提供了一种式(I)化合物的制备方法及包含本发明化合物的药物组合物及其用途。动物试验表明，本发明化合物具有良好的药代动力学参数和治疗效果。

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

Patent Metadata

Patent number: CN109020958A
Jurisdiction: CN
Classification: —
Expires: 2018-12-18
Drug substance claim: No
Drug product claim: No
Assignee: Hunan Huateng Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.